April 29 | 2020 2cureX German subsidiary receives a grant contribution to support the activities towards automation of the IndiTreat® test Read more
April 29 | 2020 2cureX German subsidiary receives a grant contribution to support the activities towards automation of the IndiTreat® test Read more
April 6 | 2020 2cureX, Germany receives an additional grant for adapting IndiTreat® to guide immunotherapy of ovarian cancer patients Read more
April 6 | 2020 2cureX i Tyskland får bidrag för att anpassa IndiTreat® för vägledning av immunterapi mot äggstockscancer Read more
April 2 | 2020 2cureX establish clinical partnership with Skåne University Hospital, Sweden Read more
March 23 | 2020 2cureX provides update regarding the COVID-19 impact on ongoing clinical programs Read more
March 23 | 2020 2cureX provides update regarding the COVID-19 impact on ongoing clinical programs Read more
March 12 | 2020 COVID-19 precautions: Remote setup secure continued sample screening supporting cancer patients Read more
March 12 | 2020 Försiktighetsåtgärder med anledning av COVID-19: Insatser på distans säkrar fortsatt screening av prov till stöd för cancerpatienter Read more
March 6 | 2020 2cureX is accelerating the commercialization of IndiTreat® by signing two distributor agreements to prepare for launch in second half of 2020 Read more
March 6 | 2020 2cureX ökar takten i kommersialiseringen av IndiTreat® – tecknar två nya distributörsavtal inför lansering andra halvan av 2020 Read more